Antigens, Neoplasm

"Antigens, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.

Descriptor ID	D000951
MeSH Number(s)	D23.050.285
Concept/Terms	Antigens, Neoplasm Antigens, Neoplasm Neoplasm Antigens Tumor Antigens Tumor Antigens Antigens, Tumor

Below are MeSH descriptors whose meaning is more general than "Antigens, Neoplasm".

Chemicals and Drugs [D]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Neoplasm [D23.050.285]

Below are MeSH descriptors whose meaning is related to "Antigens, Neoplasm".

Below are MeSH descriptors whose meaning is more specific than "Antigens, Neoplasm".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antigens, Neoplasm" by people in this website by year, and whether "Antigens, Neoplasm" was a major or minor topic of these publications.

Bar chart showing 726 publications over 31 distinct years, with a maximum of 39 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	9	11	20
1993	3	5	8
1994	3	2	5
1995	3	2	5
1996	8	6	14
1997	9	4	13
1998	9	7	16
1999	5	11	16
2000	10	7	17
2001	8	21	29
2002	14	12	26
2003	12	18	30
2004	17	18	35
2005	18	19	37
2006	23	16	39
2007	17	16	33
2008	26	5	31
2009	13	9	22
2010	12	18	30
2011	16	14	30
2012	18	17	35
2013	17	12	29
2014	14	14	28
2015	15	14	29
2016	9	10	19
2017	15	12	27
2018	13	13	26
2019	15	11	26
2020	11	17	28
2021	10	7	17
2022	2	4	6

Below are the most recent publications written about "Antigens, Neoplasm" by people in Profiles.

Hsieh RC, Krishnan S, Wu RC, Boda AR, Liu A, Winkler M, Hsu WH, Lin SH, Hung MC, Chan LC, Bhanu KR, Srinivasamani A, De Azevedo RA, Chou YC, DePinho RA, Gubin M, Vilar E, Chen CH, Slay R, Jayaprakash P, Hegde SM, Hartley G, Lea ST, Prasad R, Morrow B, Couillault CA, Steiner M, Wang CC, Venkatesulu BP, Taniguchi C, Kim YSB, Chen J, Rudqvist NP, Curran MA. ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer. Sci Immunol. 2022 Jun 10; 7(72):eabl9330.

View in: PubMed
Elfrink S, Ter Beest M, Janssen L, Baltissen MP, Jansen PWTC, Kenyon AN, Steen RM, de Windt D, Hagemann PM, Hess C, van Spronsen DJ, Hoevenaars B, van der Spek E, Xu-Monette ZY, Young KH, Kaffa C, Bervoets S, van Heek J, Hesius E, de Winde CM, Vermeulen M, van den Brand M, Scheijen B, van Spriel AB. IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma. Blood Adv. 2022 04 12; 6(7):2254-2266.

View in: PubMed
Naghizadeh A, Tsao WC, Hyun Cho J, Xu H, Mohamed M, Li D, Xiong W, Metaxas D, Ramos CA, Liu D. In vitro machine learning-based CAR T immunological synapse quality measurements correlate with patient clinical outcomes. PLoS Comput Biol. 2022 03; 18(3):e1009883.

View in: PubMed
Jiang C, Schaafsma E, Hong W, Zhao Y, Zhu K, Chao CC, Cheng C. Influence of T Cell-Mediated Immune Surveillance on Somatic Mutation Occurrences in Melanoma. Front Immunol. 2021; 12:703821.

View in: PubMed
Chang K, McAllister F, Vilar E. Transcriptomic-Assisted Immune and Neoantigen Profiling in Premalignancy. Methods Mol Biol. 2022; 2435:95-105.

View in: PubMed
Blumenschein GR, Devarakonda S, Johnson M, Moreno V, Gainor J, Edelman MJ, Heymach JV, Govindan R, Bachier C, Doger de Spéville B, Frigault MJ, Olszanski AJ, Lam VK, Hyland N, Navenot JM, Fayngerts S, Wolchinsky Z, Broad R, Batrakou D, Pentony MM, Sanderson JP, Gerry A, Marks D, Bai J, Holdich T, Norry E, Fracasso PM. Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer. J Immunother Cancer. 2022 01; 10(1).

View in: PubMed
Viswanath DI, Liu HC, Huston DP, Chua CYX, Grattoni A. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. Biomaterials. 2022 01; 280:121297.

View in: PubMed
Storkus WJ, Maurer D, Lin Y, Ding F, Bose A, Lowe D, Rose A, DeMark M, Karapetyan L, Taylor JL, Chelvanambi M, Fecek RJ, Filderman JN, Looney TJ, Miller L, Linch E, Lowman GM, Kalinski P, Butterfield LH, Tarhini A, Tawbi H, Kirkwood JM. Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma. J Immunother Cancer. 2021 11; 9(11).

View in: PubMed
Potter VL, Moye AR, Robichaux MA, Wensel TG. Super-resolution microscopy reveals photoreceptor-specific subciliary location and function of ciliopathy-associated protein CEP290. JCI Insight. 2021 10 22; 6(20).

View in: PubMed
Kim ST, Tayar J, Fu S, Ke D, Norry E, Sun A, Miller J, Hong DS. Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab. J Immunother Cancer. 2021 07; 9(7).

View in: PubMed

People

Explore

Similar Concepts

Top Journals